Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Current Assets
Cash	$ 141,379	$ 182,561
Trade accounts receivable, net	398,770	444,743
Other receivables		2,250
Product deposit	16,500
Inventory, net	707,161	160,270
Total Current Assets	1,263,810	789,824
Current Liabilities
Accounts payable and accrued expenses	473,492	752,930
Derivative liabilities		192,254
Line of credit	42,479
Convertible notes payable		100,000
Notes payable - related parties	125,000
Short-term notes payable, net of discount in 2016		106,365
Total Current Liabilities	640,971	1,151,549
Stockholders' Equity (Deficit)
Common stock, $0.01 par value; 100,000,000 shares authorized, 44,493,063 and 35,570,157 shares issued, 43,977,863 and 35,245,157 outstanding as of December 31, 2017 and 2016, respectively	444,930	355,701
Additional paid-in capital	11,500,537	9,070,064
Accumulated (deficit)	(10,899,843)	(9,693,882)
Equity	1,045,624	(268,117)
Treasury stock, 515,200 and 325,000 shares, at cost	(163,701)	(87,053)
Total Immudyne, Inc. Stockholders' (Deficit)	881,923	(355,170)
Non-controlling interest	(259,084)	(6,555)
Total Stockholders' Equity (Deficit)	622,839	(361,725)
Total Liabilities and Stockholders' Equity (Deficit)	$ 1,263,810	$ 789,824

It represents total of common stock, additional paid in capital and accumulated deficit.

No definition available.

Name:	immd_Equity
Namespace Prefix:	immd_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.